Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of the BraveBot Intervention as an Adjunctive Treatment for Young People With Anxiety and Related Disorders Receiving Outpatient, Exposure-Based Cognitive Behavioral Therapy

NCT07666672 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07666672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07666672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of the BraveBot Intervention as an Adjunctive Treatment for Young People With Anxiety and Related Disorders Receiving Outpatient, Exposure-Based Cognitive Behavioral Therapy
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2027
Completion date
July 31, 2027
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, ocd